Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Preclinical Trials Drives Growth In The Preclinical CRO Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Preclinical CRO Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year, with a compound annual growth rate (CAGR) of 9.9%. Various factors can explain the growth observed in the historical period, including the need for more rapid drug development, cost reduction tactics, a concentration on core competencies, the need to meet regulatory compliance standards, and the international expansion of clinical trials.

How Will the Preclinical CRO Market Size Evolve and Grow by 2029?
In the coming years, the preclinical CRO market is anticipated to undergo robust expansion, reaching $9.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.7%. The amplified emphasis on individualized medicine, interest in rare diseases and orphan drugs, the surge in outsourcing within the biopharmaceutical industry, focus on biomarker research, and the necessity for real-world evidence creation contribute to this expected growth during the forecast period. The future of this market is also likely to be shaped by major trends including the incorporation of artificial intelligence (AI), the broadening scope of oncology research, developments in omics technologies, advancements in both in vitro and in vivo models, and partnerships for translational research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

What Drivers Are Propelling the Growth of Preclinical CRO Market Forward?
The rise in preclinical trials is projected to fuel the advancement of the preclinical Contract Research Organization (CRO) market. These trials are essentially studies of treatments or drugs for any given condition conducted before human subjects are used for testing. Preclinical investigations usually deal with new medical devices, prescription drugs, and diagnostic tools. They primarily aim to determine a starting, safe dosage for initial human research and assess any potential toxicity of the substance under review. As crucial elements in drug development, the prominence of preclinical trials is escalating amid growing focus on the safety and efficiency of new drugs. For example, the productivity of clinical development as per IQVIA - a US company offering services to both the health information technology and the clinical research industries - increased in 2023. Globally, a total of 69 novel active substances (NASs) were launched which was an increase of 6 from the previous year, and it included 24 first-in-class launches in the U.S. This mounting requirement for preclinical trials is, therefore, helping drive the expansion of the preclinical CRO market into the future.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

Which Emerging Trends Are Transforming the Preclinical CRO Market in 2025?
Technological advances are transforming the preclinical CRO market. In February 2023, Canada-based BenchSci launched ASCEND, an AI-powered SaaS platform for drug discovery. The software uses machine learning to extract and analyze data from various sources, mapping disease processes and accelerating early-phase pharmaceutical research.

What Are the Key Segments in the Preclinical CRO Market?
The preclinical CRO market covered in this report is segmented -

1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies
6) By Other Services: Regulatory Consulting, Project Management, Data Management Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp

Who Are the Key Players Shaping the Preclinical CRO Market's Competitive Landscape?
Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

What Geographic Markets Are Powering Growth in the Preclinical CRO Market?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10303

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.